When injected into the muscle, passes quickly and easily into the blood stream and aids the formation of red blood cells, vital for carrying oxygenated blood around the body
4 A history of gallbladder disease A 2022 systematic review of 76 randomised trials found that GLP-1 medications are associated with a relative risk of around 37% for gallbladder or biliary disease, with a higher relative risk in weight-loss trials than in diabetes trials
Preliminary research suggests individuals with metabolic syndrome, type 2 diabetes, or obesity might have altered NAD+ dynamics, though much of this evidence comes from animal studies
Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH